Lee Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,003
Closed -$520K 154
2024
Q1
$520K Hold
1,003
0.09% 93
2023
Q4
$473K Buy
1,003
+983
+4,915% +$455K 0.08% 97
2023
Q3
$8.71K Hold
20
﹤0.01% 435
2023
Q2
$8.89K Sell
20
-11
-35% -$5.07K ﹤0.01% 425
2023
Q1
$14.3K Sell
31
-5
-14% -$2.38K ﹤0.01% 363
2022
Q4
$18.5K Hold
36
﹤0.01% 352
2022
Q3
$16K Buy
36
+1
+3% +$478 ﹤0.01% 356
2022
Q2
$17K Buy
35
+20
+133% +$9.89K ﹤0.01% 356
2022
Q1
$7K Sell
15
-2
-12% -$914 ﹤0.01% 482
2021
Q4
$8K Buy
17
+2
+13% +$841 ﹤0.01% 538
2021
Q3
$6K Buy
15
+5
+50% +$1.9K ﹤0.01% 478
2021
Q2
$4K Buy
+10
New +$3.82K ﹤0.01% 480
2020
Q4
Sell
-10
Closed -$3K 493
2020
Q3
$3K Hold
10
﹤0.01% 488
2020
Q2
$3K Hold
10
﹤0.01% 461
2020
Q1
$2K Sell
10
-100
-91% -$27.3K ﹤0.01% 435
2019
Q4
$33K Hold
110
0.01% 217
2019
Q3
$26K Hold
110
0.01% 233
2019
Q2
$31K Hold
110
0.01% 228
2019
Q1
$32K Buy
+110
New +$31.8K 0.01% 212

Other funds holding ELV

Lee Financial's ELV Position: Q2 2024 in Review

Lee Financial sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 1,003 shares — an estimated $520K sold.

Lee Financial first reported a position in ELV in Q1 2019 and held it in 19 quarters. The position peaked at $520K in Q1 2024. 1,705 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

  • Lee Financial reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
  • Lee Financial sold 1,003 Elevance Health shares in Q2 2024, an estimated $520K.
  • Lee Financial first reported a position in Elevance Health in Q1 2019 and held it in 19 quarters.
  • Lee Financial's Elevance Health position peaked at $520K in Q1 2024.
  • 1,705 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on Lee Financial's 13F filing for Q2 2024, filed 14 Aug 2024.